Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Antibacterial activity of Manuka honey and its components: An overview

1 Biomedical Sciences Research Institute, Ulster University, Coleraine BT52 1SA, Northern Ireland, UK
2 Department of Clinical Sciences and Nutrition, Faculty of Medicine, Dentistry and Life Sciences, University of Chester, Chester CH1 4BJ, UK

The importance of honey for medicinal purposes is well documented in some of the world’s oldest literature. Honey is well known and studied for its antimicrobial properties. The medicinal properties in honey originate from the floral source used by bees. Manuka honey is a dark monofloral honey rich in phenolic content, and currently it is gaining much attention for its antimicrobial activity. Researchers have found that honey is effective against a wide range of pathogens. The antibacterial potency of Manuka honey was found to be related to the Unique Manuka Factor (UMF) rating, which is correlated with the methylglyoxal and total phenols content. It is reported that different types of Manuka honey have differing effects and Gram-negative bacteria are more resistant than Gram-positive bacteria. Bacterial resistance to honey as antimicrobial agent has yet to be identified, possibly due to the presence of a complex mixture of methylglyoxal and other components. Honey is also reported to alter a bacterium’s shape and size through septal ring alteration, which affects cell morphology and growth. Research has shown that Manuka honey of different UMF values has medicinal properties of interest and it can be beneficial when used as a combination treatment with other antimicrobial agents.
  Article Metrics


1. Linder K, Nicolau D, Nailor M (2016) Predicting and preventing antimicrobial resistance utilizing pharmacodynamics: Part I Gram positive bacteria. Expert Opin Drug Met 12: 267–280.    

2. Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406: 775–781.    

3. Pagès JM, Amaral L (2009) Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. BBA-Proteins Proteom 1794: 826–833.    

4. Coates R, Moran J, Horsburgh M (2014) Staphylococci: colonizers and pathogens of human skin. Future Microbiol 9: 75–91.    

5. Tong S, Davis J, Eichenberger E, et al. (2015) Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 28: 603–661.    

6. Miragaia M, Thomas J, Couto I, et al. (2007) Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. J Bacteriol 189: 2540–2552.    

7. Uckay I, Pittet D, Vaudaux P, et al. (2009) Foreign body infections due to Staphylococcus epidermidis. Ann Med 41: 109–119.    

8. Otto M (2009) Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol 7: 555–567.    

9. Saeed S, Farkhondeh T, Fariborz S (2018) Honey and health: A review of recent clinical research. Pharmacogn Res 9: 121–127.

10. Wijesinghe M, Weatherall M, Perrin K, et al. (2009) Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. NZ Med J 122: 47–60.

11. Alvarez-Suarez J, Gasparrini M, Forbes-Hernández T, et al. (2014) The composition and biological activity of honey: a focus on Manuka honey. Foods 3: 420–432.    

12. Mavric E, Wittmann S, Barth G, et al. (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52: 483–489.    

13. Adams CJ, Manley-Harris M, Molan PC (2009) The origin of methylglyoxal in New Zealand Manuka (Leptospermum scoparium) honey. Carbohyd Res 344: 1050–1053.    

14. Atrott J, Henle T (2009) Methylglyoxal in Manuka honey-correlation with antibacterial properties. Czech J Food Sci 27: S163–S165.    

15. Kato Y, Fujinaka R, Ishisaka A, et al. (2014) Plausible authentication of Manuka honey and related products by measuring leptosperin with methyl syringate. J Agr Food Chem 62: 6400–6407.    

16. Molan PC (2008) An explanation of why the MGO level in Manuka honey does not show the antibacterial activity. New Zeal Beekeeper 16: 11–13.

17. Tonks AJ, Dudley E, Porter N, et al. (2007) A 5.8-kDa component of Manuka honey stimulates immune cells via TLR4. J Leukocyte Biol 82: 1147–1155.

18. Henderson K, Aldhirgham T, Nigam P, et al. (2016) Evaluation of Manuka honey estrogen activity using the MCF-7 cell proliferation assay. J Adv Biol Biotechnol 10: 1–11.

19. Portokalakis I, Yusof H, Ghanotakis D, et al. (2016) Manuka honey-induced cytotoxicity against MCF7 breast cancer cells is correlated to total phenol content and antioxidant power. J Adv Biol Biotechnol 8: 1–10.

20. Fernandez-Cabezudo M, El-Kharrag R, Torab F, et al. (2013) Intravenous administration of Manuka honey inhibits tumour growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model. PLoS One 8: e55993.    

21. Kwok T, Kirkpatrick G, Yusof H, et al. (2016) Rapid colorimetric determination of methylglyoxal equivalents for Manuka honey. J Adv Biol Biotechnol 7: 1–6.

22. Henderson T, Nigam PS, Owusu-Apenten RK, et al. (2015) A universally calibrated microplate ferric reducing antioxidant power (FRAP) assay for foods and applications to Manuka honey. Food Chem 174: 119–123.    

23. Al-Waili N, Ghamdi AA, Ansari MJ, et al. (2013) Differences in composition of honey samples and their impact on the antimicrobial activities against drug multi-resistant bacteria and pathogenic fungi. Arch Med Res 44: 307–316.    

24. Tonks A (2003) Honey stimulates inflammatory cytokine production from monocytes. Cytokine 21: 242–247.    

25. Lu J, Carter D, Turnball L, et al. (2013) The effect of New Zealand Kanuka, Manuka and clover honeys on bacterial growth dynamics and cellular morphology varies according to the species. PLoS One 8: e55898.    

26. Henriquez A, Jenkins R, Burton N, et al. (2010) The intracellular effects of Manuka honey on Staphylococcus aureus. Eur J Clin Microbiol 29: 45–50.    

27. Lu J, Turnball L, Burke CM, et al. (2014) Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities. Peer J 2: e326.

28. Cooper R, Jenkins L, Henriquez A, et al. (2010) Absence of bacterial resistance to medical-grade Manuka honey. Eur J Clin Microbiol 29: 1237–1241.    

29. Bonifacio M, Cometa S, Cochis A, et al. (2018) Antibacterial effectiveness meets improved mechanical properties: Manuka honey/gellan gum composite hydrogels for cartilage repair. Carbohyd Polym 198: 462–472.    

30. Almasaudi SB, Al-Nahari AAM, EI Sayd M, et al. (2017) Antimicrobial effect of different types of honey on Staphylococcus aureus. Saudi J Biol Sci 24: 1255–1261.    

31. Alsarra I (2009) Chitosan topical gel formulation in the management of burn wounds. Int J Biol Macromol 45: 16–21.    

32. Chau T, Owusu-Apenten R, Nigam P (2017) Total phenols, antioxidant capacity and antibacterial activity of Manuka honey extract. J Adv Biol Biotech 15: 1–6.

33. Kirkpatrick G, Nigam P, Owusu-Apenten R (2017) Total phenols, antioxidant capacity and antibacterial activity of Manuka honey chemical constituents. J Adv Biol Biotech 15: 1–7.

34. Irish J, Blair S, Carter D (2011) The antibacterial activity of honey derived from Australian flora. PLoS One 6: e18229.    

35. Kumar N (2014) Comparison of the antibacterial efficacy of Manuka honey against E. faecalis and E. coli-An in vitro study. JCDR 8: ZC29–ZC31.

36. Paramasivan S, Drilling A, Jardeleza C, et al. (2014) Methylglyoxal-augmented Manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model. Int Forum Allergy Rh 4: 187–195.    

37. Schneider M, Coyle S, Warnock M, et al. (2012) Anti-microbial activity and composition of Manuka and Portobello honey. Phytother Res 27: 1162–1168.

38. Jenkins R, Cooper R (2012) Synergy between oxacillin and Manuka honey sensitizes methicillin-resistant Staphylococcus aureus to oxacillin. J Antimicrob Chemoth 67: 1405–1407.    

39. Müller P, Alber D, Turnbull L, et al. (2013) Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA). PLoS One 8: e57679.    

40. Liu M, Cokcetin N, Lu J, et al. (2017) Rifampicin-Manuka honey combinations are superior to other Antibiotic-Manuka honey combinations in eradicating Staphylococcus aureus biofilms. Front Microbiol 8: 1–12.

© 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Article outline

Show full outline
Copyright © AIMS Press All Rights Reserved